Hillsdale Investment Management »

Fennec Pharmaceuticals shares owned by Hillsdale Investment Management

Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by Hillsdale Investment Management from 13F filings

Historical chart of Hillsdale Investment Management investment in Fennec Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fennec Pharmaceuticals held by Hillsdale Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fennec Pharmaceuticals by Hillsdale Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $339k 44k 7.70
2024-06-30 $150k 25k 6.11

More positions owned by Hillsdale Investment Management

Rbc Cad (RY)
Cibc Cad (CM)
Tor Dom Bk Cad (TD)
Bk Nova Cad (BNS)
Shopify Inc cl a (SHOP)
Enerflex (EFXT)
Agnico (AEM)
Bank Of Montreal Cadcom (BMO)
Enbridge (ENB)
Barrick Mining Corp (B)
Centerra Gold (CGAU)
Ero Copper Corp (ERO)
NVIDIA Corporation (NVDA)
Wheaton Precious Metals Corp (WPM)
Fortis (FTS)

View all positions for Hillsdale Investment Management

Top funds holding Fennec Pharmaceuticals

Southpoint Capital Advisors
Rosalind Advisors
Solas Capital Management
AIGH Capital Management
BlackRock
Vanguard Group
AWM Investment Company
State Street Corporation
Geode Capital Management
Apis Capital Advisors
Jeffrey L. Gendell
Marshall Wace
Lion Point Capital
Northern Trust
Citadel Advisors

View all funds holding Fennec Pharmaceuticals